AGN 193109
SIGMA/SML2034 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 171746-21-7
Empirical Formula (Hill Notation): C28H24O2
Molecular Weight: 392.49
MDL Number: MFCD00943817
Linear Formula: C28H24O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C28H24O2/c1-19-4-11-22 |
| InChI key | NCEQLLNVRRTCKJ-UHFFFAOYSA |
| SMILES string | O=C(O)C1=CC=C(C#CC2=CC=C3 |
| solubility | DMSO: 2 mg/mL, clear (warmed) |
| storage temp. | −20°C |
| Biochem/physiol Actions: | AGN 193109 is an orally active retinoic acid receptor (RAR) antagonist that targets all three RAR subtypes with higher affinity (RARα/β/γ Kd = 2 nM) than all-trans retinoic acid/ATRA (RARα/β/γ Kd = 9/12/19 nM). AGN 193109 potently antagonizes against ATRA-induced transcription in RARα, RARβ, and RARγ transfected CV-1 cells (by 85%, 62%, and 100%, respectively, by equal molar AGN 193109 against ATRA). AGN 193109 is also widely employeed to block RAR-mediated physiological and pathalogical processes in mice and rats in vivo via oral (1-10 mg/kg) or topical (0.3-36 μmol/kg) administration. |
| Biochem/physiol Actions: | High-affinity orally active pan-retinoic acid receptor (RAR) antagonist with in vitro and in vivo efficacy. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |
